Who to call at Halozyme Therapeutics, Inc, and when
Fundz watches for the moments Halozyme Therapeutics, Inc starts buying, and tells you who to reach.
- An alert the day Halozyme Therapeutics, Inc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Halozyme Therapeutics, Inc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Halozyme Therapeutics, Inc. With Fundz connected, it knows.
Halozyme Therapeutics, Inc
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
halozyme.com2 executive changes at Halozyme Therapeutics in the last 90 days. Clusters like this usually mean more senior seats open over the next few months.
See every company with multiple executive changes →AI Executive Summary
AI-powered analysis of 8-K filing content
Halozyme Therapeutics announced that CFO Nicole LaBrosse will depart after the earlier of a successor's hire or March 30, 2026, and the company has begun a search for her replacement. The filing states the departure is not the result of any disagreement with the auditors or the company on financial, operational, or policy matters.
Key Takeaways
Nicole LaBrosse, Senior Vice President and Chief Financial Officer, will remain in the role until the earlier of a new CFO being hired or March 30, 2026 (the Separation Date), then leave to pursue a n
Halozyme has initiated a search for its next CFO, so the timing of the transition depends on how quickly a qualified successor is identified.
3 more takeaways
Related Filings (13)
13 more filings from Halozyme Therapeutics, Inc in the last 90 days
Filing Overview
What This Means
Halozyme Therapeutics, Inc filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.